Psychopharmacomania™ is a mental or emotional disorder caused by the ingestion of too much end-product of the psychopharmacological digestive tract. It results in varying degrees of intractable depression, permanent psychosis, and brain damage – depending on which drug rep reaches your doctor first.
Twenty physicians were responsible for the American Psychiatric Association’s treatment guidelines. Ninety percent of the 20 received incentives from drug companies – which they failed to report – and 100% of those physicians recommended the drug from the company that paid them. That is how the APA’s clinical guidelines were created.
Drug reps frequent doctors’ offices, take them out to dinner, give them enticements to interest them in their products. They target non-psychiatrists, in hopes that every primary care physician will know exactly what to prescribe for their patients. They educate them with psychopharmacological babble. One pharmaceutical company placed an ad that was seven full pages, in color, in every issue of the American Medical News, for about one full year – until everyone was well educated as to what “cures” depression. The problem is, these antidepressants are barely more effective than placebo, and treated patients have been shown to be less likely to return to normal functioning and more likely to become incapacitated (Am J Psychiatry 152; 1124-29).
Nonetheless, this has infiltrated the psychiatric community to the extent that in medical schools in Philadelphia, psychotherapy has not been taught for fifteen years. The powerful influence of billions of drug company dollars has reached the full extent of total degradation of real therapy and treatment of the mentally ill.
What is Pharmacomania
Pharmacomania as defined by Webster’s dictionary: An uncontrollable desire to administer drugs. A morbid impulse to take drugs. A craze for using or trying drugs. A chronic fascination with medicines. A mania for medicines. Pharmacomania causes Psychopharmacomania.